Angiotensin receptor blockers could improve response to cancer immunotherapy

[News]

A research team led by investigators at Massachusetts General Hospital and the Massachusetts Institute of Technology has found that combining a specialized version of an antihypertension drug with immune checkpoint blockers could increase the effectiveness of cancer immunotherapies.

More... (https://www.news-medical.net/news/20190430/Angiotensin-receptor-blockers-could-improve-response-to-cancer-immunotherapy.aspx)